HLS Therapeutics Inc's total assets for Q1 2026 were $131.18M, a decrease of -4.44% from the previous quarter. TSE:HLS total liabilities were $72.57M for the fiscal quarter, a -4.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.